News

Memo Therapeutics has brought to notice the start of a clinical trial in renal transplant patients to treat BK polyomavirus (BKV) infection.The safety, tolerability, and pharmacokinetics of MTX-005 will be assessed in a phase 1 single-blind, partially randomised, and placebo-controlled...

Jubilant HollisterStier has grabbed a $146.6 million contract from the US government, continuing to ride the industrial expansion wave created by the COVID-19 business boom. The contract, which was signed with numerous agencies of the Department of Health and...

Sandoz, a biosimilars manufacturer, has announced the beginning of a new global campaign to combat global health disparities. By harnessing the '4 As' of biosimilars- approval, accessibility, acceptability, and affordability, Act4Biosimilars strives to expand patient access to innovative treatments....

After the United Kingdom and Argentina presented a "landmark" decision to the World Health Assembly in Geneva recently, the world took a huge step toward greater pandemic preparedness. More specific financing will be advocated for within the resolution, allowing developing...

The US Food and Drug Administration (FDA) has granted Novartis expedited approval for its CAR-T cell therapy Kymriah (tisagenlecleucel) to treat people with relapsed or refractory (r/r) follicular lymphoma (FL) following two or more lines of conventional therapy. As part...

NRG Therapeutics, a neuroscience firm, has been presented with the Biomedical Catalyst award. The £2.68 million package will be used to advance the pre-clinical development of the company's innovative small molecule disease-modifying medicines for the treatment of Parkinson's disease,...

The United Kingdom and Sweden have reached a deal through an MoU recognising their existing bilateral collaboration in the biological sciences. The goal of the MoU is to foster collaboration among participants in the health, research, as well as innovation systems...